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copper centers (CuA and CuB) and two hemes — low-spin heme a and
high-spin heme a3. Despite many years of research, the individual
absolute absorption spectra of the two hemes in the Soret band (420–
460 nm) have not yet been resolved because they overlap strongly.
There is but a single classical work of Vanneste [1] reporting the
absolute individual spectra of the reduced hemes a and a3. We revisited
the problem with new approaches as summarized below.
(1) Calcium binding tomitochondrial COX induces a small red shift
of the absorption spectrum of heme a. Treating the calcium-induced
difference spectrum as the ﬁrst derivative (differential) of the ab-
sorption spectrum of the reduced heme a, it is possible to reconstruct
the line shape of the parent absolute spectrum of a2+ by integration.
The Soret band absolute spectrum of the reduced heme a obtained in
this way differs strongly form that in ref. [1]. It is fairly symmetric and
can be easily approximated by two 10 nm Gaussians with widely split
maxima at 442 and 451 nm. In contrast to Vanneste, no evidence for
the ~428 nm shoulder is observed for heme a2+.
(2) The overall Soret band of the reduced COX reveals at least 5
more Gaussians that are not affected by Ca2+. Two of them at 436
and 443 nm can be attributed to electronic B0 transitions in heme a3,
and two more can represent their vibronic satellites.
(3) A theoretical dipole–dipole interaction model was developed
[2] for calculation of absorption and CD spectra. The model allows to
optimize parameters of the Bx,y electronic transitions in the hemes a
and a3 to obtain best ﬁt to the experimental spectra. The optimized
parameters agree with the characteristics of the reconstructed spectra
of hemes a and a3.
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The Flavodiiron proteins (FDPs) are present in all life domains,
from unicellular microbes to higher eukaryotes. FDPs reduce oxygen
to water and/or nitrous oxide to nitrous oxide, actively contributing
to combat the toxicity of O2 or NO. The catalytic ability of FDPs is
comparable to that of bona ﬁde heme–copper/iron O2/NO transmem-
brane reductases. FDPs are multi-modular water soluble enzymes,
exhibiting a two-domain catalytic core, whose the minimal functional
unit is a ‘head-to-tail’ homodimer, each monomer being built by a
beta-lactamase domain harbouring a diiron catalytic site, and a short-
chain ﬂavodoxin, binding FMN [1–3].
Despite extensive data collected on FDPs, the molecular determi-
nants deﬁning their substrate selectivity remain unclear. To clarify this
issue, two FDPs with known and opposite substrate preferences were
analysed and compared: the O2-reducing FDP from the eukaryote
Entamoeba histolytica (EhFdp1) and the NO reductase FlRd from
Escherichia coli. While themetal ligands are strictly conserved in these
two enzymes, differences near the active site were observed. Single
and double mutants of the EhFdp1 were produced by replacing the
residues in these positions with their equivalent in the E. coli FlRd. The
biochemical and biophysical features of the EhFdp1 WT and mutants
were studied by potentiometric-coupled spectroscopic methods (UV–
visible and EPR spectroscopies). The O2/NO reactivity was analysed by
amperometric methods and stopped-ﬂow absorption spectroscopy.
The reactivity of the mutants towards O2 was negatively affected,
while their reactivity with NO was enhanced. These observations
suggest that the residues mutated have a role in deﬁning the substrate
selectivity and reaction mechanism.
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oxidase and essential for assembly and stability of the di-heme
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The cytochrome bd ubiquinol oxidase is part of many prokaryotic
respiratory chains. It catalyzes the oxidation of ubiquinol to ubiqui-
none while reducing molecular oxygen to water. The reaction is
coupled to the vectorial transfer of 1 H+/e− across the membrane,
contributing to the proton motive force essential for energy consum-
ing processes. The presence of this terminal oxidase is known to be
related to the virulence of several human pathogens, making it a very
attractive drug target. The three heme groups of the oxidase are
presumably located in subunit CydA. Heme b558 is involved in
ubiquinol oxidation, while the reduction of molecular oxygen is
catalyzed by a di-nuclear heme center containing hemes b595 and d
[1]. A severe change in Escherichia coli phenotype was noticed when a
111 nt gene, denoted as cydX and located at the 5′ end of the cyd
operon, was deleted. This small gene codes for a single transmem-
brane helix obviously needed for the activity of the oxidase [2]. We
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